| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000014312 |
| Receipt No. | R000016339 |
| Official scientific title of the study | Examination of efficacy of tolvaptan for chronic congective heart failure complicated with chronic kidney disease. |
| Date of disclosure of the study information | 2014/07/01 |
| Last modified on | 2018/08/29 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Examination of efficacy of tolvaptan for chronic congective heart failure complicated with chronic kidney disease. | |
| Title of the study (Brief title) | TOLVAPTAN study | |
| Region |
|
|
| Condition | ||
| Condition | Chronic congestive heart failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine effects of tolvaptan for chronic heart failure with chronic kidney disease. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Improvement effect of the heart failure |
| Key secondary outcomes | BNP, renin activity, aldosteron, catecholamine, CRE, cystatin C, urine L-FABP |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Tolvaptan | |
| Interventions/Control_2 | Furosemide | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients of congestive heart failure hospitalized with the chronic kidney disease that presented body fluid retention even if taken more than furosemide 20mg/day. | |||
| Key exclusion criteria | Patients who had acute myocardial infarction within 30 days .
Patients of active myocarditis or the amyloid cardiomyopathy. Patients who are supported by circulation device. Patients who had decrease in circulation blood volume. Patients with hypertrophic cardiomyopathy (except the expansion aspect). Patients with severe valvular disease. Patients with hepatogenic comatose. Patients with insufficient treatment on diabetes mellitus. Patients whose blood pressure is less than 90mmHg. Patients that following electrolytes abnormality is accepted. Serum Na>147mEq/L, serum K>5.5mEq/L Patients who cannot take oral formulation. Patients with a pregnant woman, a nursing girl, pregnant possibility or the intention to become pregnant. Patients that are recognized as inappropriate for this study. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Shinya Minatoguchi |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Department of Cardiology |
| Address | 1-1 Yanagido, Gifu |
| TEL | 058-230-6523 |
| minatos@gifu-u.ac.jp | |
| Public contact | |
| Name of contact person | Shinya Minatoguchi |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Department of Cardiology |
| Address | 1-1 Yanagido, Gifu |
| TEL | 058-230-6523 |
| Homepage URL | |
| minatos@gifu-u.ac.jp | |
| Sponsor | |
| Institute | Department of Cardiology, Gifu University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Cardiology, Gifu University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016339 |